McKesson Corporation (MCK) : Bank Of The Ozarks scooped up 175 additional shares in McKesson Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 12, 2016. The investment management firm now holds a total of 10,812 shares of McKesson Corporation which is valued at $2,110,935.McKesson Corporation makes up approximately 0.77% of Bank Of The Ozarks’s portfolio.
Other Hedge Funds, Including , Delphi Private Advisors boosted its stake in MCK in the latest quarter, The investment management firm added 7 additional shares and now holds a total of 9 shares of McKesson Corporation which is valued at $1,757.Pillar Pacific Capital Management boosted its stake in MCK in the latest quarter, The investment management firm added 10 additional shares and now holds a total of 2,435 shares of McKesson Corporation which is valued at $475,166. McKesson Corporation makes up approx 0.08% of Pillar Pacific Capital Management’s portfolio.Alps Advisors Inc reduced its stake in MCK by selling 189 shares or 6.37% in the most recent quarter. The Hedge Fund company now holds 2,780 shares of MCK which is valued at $547,438.Boston Advisors reduced its stake in MCK by selling 3,264 shares or 11.99% in the most recent quarter. The Hedge Fund company now holds 23,952 shares of MCK which is valued at $4,716,628. McKesson Corporation makes up approx 0.11% of Boston Advisors’s portfolio.Physicians Financial Services reduced its stake in MCK by selling 100 shares or 25.0% in the most recent quarter. The Hedge Fund company now holds 300 shares of MCK which is valued at $59,310. McKesson Corporation makes up approx 0.05% of Physicians Financial Services’s portfolio.
McKesson Corporation opened for trading at $183.16 and hit $184.33 on the upside on Monday, eventually ending the session at $183.9, with a gain of 0.61% or 1.11 points. The heightened volatility saw the trading volume jump to 11,78,858 shares. Company has a market cap of $41,507 M.
On the company’s financial health, McKesson Corporation reported $3.50 EPS for the quarter, beating the analyst consensus estimate by $ 0.16 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $3.34. The company had revenue of $49733.00 million for the quarter, compared to analysts expectations of $50333.03 million. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.14 EPS.
Many Wall Street Analysts have commented on McKesson Corporation. Company shares were Reiterated by Mizuho on Aug 11, 2016 to “Neutral”, Firm has raised the Price Target to $ 197 from a previous price target of $174 .Company shares were Reiterated by Mizuho on Jun 7, 2016 to “Neutral”, Firm has raised the Price Target to $ 174 from a previous price target of $164 .McKesson Corporation was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers and practice management technology clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical patient care financial supply chain and strategic management software solutions as well as connectivity outsourcing and other services including remote hosting and managed services to healthcare organizations.